Cashing in Dot HIll,Cantel Medical, Buying Biotechs

I did not foresee the China mini-crisis. But I watched with fascination. Because I had little cash in my account, on August 12 I raised cash by selling my Cantel Medical (CMN) stock, all of it. Cantel is a great company making infection control devices. When I bought it in December of 2009 for $19.58 per share, after hearing about […]

Venrock’s Bryan Roberts on Digital Health Investments

Timothy Hay


With biotechnology stocks turning in stellar performances on the Nasdaq Global Exchange and digital-health startups commanding huge funding rounds at high valuations, some are talking about a bubble forming in certain areas of medical technology.But Bryan Roberts of Venrock, who last year logged six successful exits from medical technology investments, doesn’t use the word “bubble.”The industry, he said, is […]

Finding small and unloved alternatives in hot sectors

Health care and consumer staples continue to be among the best-performing sectors on North American equity markets, with both established names and emerging companies getting love from investors. But all that attention creates high valuations, raising concerns about the potential upside for future returns and what might happen if sentiment takes a turn for the worse.There are still plenty of […]

How to Pick Companies to Pitch in Hedge Fund and Private Equity Case Studies in 5 Simple Steps

Some decisions in life deserve serious, thoughtful contemplation.Other times, you have to make a split-second decision and live with the consequences.Picking companies to pitch in hedge fund and private equity case studies falls somewhere in the middle.If you already have a few companies in mind, you need to decide on one quickly – but if you have no clue where […]

A good medical-stock bet less risky than booming biotech –

The health-care sector is hot—but it’s not due just to the wild ride in booming biotech.The health-care sector as a whole has been a standout in the S&P 500, up 9 percent year-to-date through the end of May and the top sector gainer last month, with a 4 percent return. That’s compared to the S&P 500’s meager 2.3 percent for […]

ResMed : Biotech stocks at mercy of health reports

Last Thursday we saw a tale of two biotech companies. If you need evidence investing in medical research stocks is a lottery, this is the story for you.First we have Sirtex Medical, a Sydney-based company that provides radioactive treatment to help extend the lives of patients suffering from liver cancers.Its shares jumped 28 per cent after it revealed stronger-than-expected results […]

Two Stocks Stand Out In Red-Hot But Volatile Biotech Sector

The enticing if volatile biotechs continue to intrigue investors. Some of the stocks in the fast-growing sector are more alluring than many others, but make no mistake: Biotechs should not be ignored!“Biotech stocks are still in favor with investors for all the right reasons: constant M&A, solid clinical data, regulatory reviews, upcoming scientific conferences, selective stock picking, and technical support,” […]

Aethlon Medical (OTCBB: AEMD) Announces Reverse Stock Split and Nasdaq Listing Submission

Medical Technology Breaking News: Aethlon Medical (OTCBB: AEMD) Announces Reverse Stock Split and Nasdaq Listing SubmissionSAN DIEGO – April 8, 2015 ( newswire) Aethlon Medical, Inc. (OTCBB:AEMD), a pioneer in developing targeted therapeutic devices to address infectious diseases and cancer, announced today that it will implement a 1-for-50 reverse split of its common stock. The implementation of the reverse stock […]

U.S. biotech stocks may fall further as short interest rises

Short interest has risen in a number of biotech names perceived as vulnerable to a selloff after a rally that has sent the Nasdaq Biotechnology Index <.NBI> up 42 percent over the last year even after this week’s declines.Overall, a screen of about 1,650 mid-cap U.S. companies shows biotech stocks, on average, have a short interest ratio of about 11.6 […]

New Biotech ETFs Highlight Evolving Growth Opportunities

The biotechnology story is one that continues to highlight evolving growth opportunities in the medical field. Whether you are a believer in the high valuations or not, these stocks have consistently posted double digit gains for more than half a decade and enthralled investors with their resiliency. That makes biotechnology companies worthy of consideration for those that are seeking high […]